Stay updated on Pembrolizumab for Mycosis Fungoides Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Mycosis Fungoides Clinical Trial page.

Latest updates to the Pembrolizumab for Mycosis Fungoides Clinical Trial page
- Check2 days agoChange DetectedAdded a government funding lapse notice and NIH Clinical Center status guidance, and updated the site revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check10 days agoChange DetectedGlossary UI toggle added and shown on the page. Metadata labels updated to include Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0, replacing previous labels and version.SummaryDifference0.3%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedOnly revision metadata changed from v3.3.3 to v3.3.4; no substantive content, study details, or page functionality were modified. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check45 days agoChange DetectedAdded a Locations section indicating Florida as a study site and removed the prior Florida Locations entry. Page revision updated to v3.3.3.SummaryDifference0.2%

- Check73 days agoChange DetectedThe page now displays Revision: v3.3.2, replacing Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedRemoved the general government funding/status notice from the page; study details including eligibility criteria remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab for Mycosis Fungoides Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Mycosis Fungoides Clinical Trial page.